Showing results (151-160 of 219) with videos related to
Sort By:
Pageof 22
Journal of Medical Economics|July 7, 2017
Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phaseElias J Jabbour, Jay Lin, Lisa R Siegartel, et al.The Journal of Dermatological Treatment|April 17, 2018
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United StatesJashin J Wu, Steven R Feldman, Shipra Rastogi, et al.Journal of Medical Economics|January 24, 2018
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plansSteven R Feldman, Jashin J Wu, Shipra Rastogi, et al.Journal of Medical Economics|January 31, 2013
Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychoticsRimal Bera, Steve Offord, Donna Zubek, et al.Advances in Therapy|July 24, 2020
Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USASteven B Deitelzweig, Belinda Lovelace, Mary Christoph, et al.Journal of Medical Economics|August 4, 2018
Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic modelElias J Jabbour, Lisa R Siegartel, Jay Lin, et al.Inflammatory Bowel Diseases|September 1, 2017
Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton PlacementDavid A Schwartz, Anthony Wang, Burak Ozbay, et al.Journal of Medical Economics|May 16, 2019
Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the USAlpesh Amin, Steven Deitelzweig, Iwona Bucior, et al.Journal of Medical Economics|October 15, 2020
Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulantsGregory J Fermann, Belinda Lovelace, Mary J Christoph, et al.Psychiatric Research and Clinical Practice|September 14, 2022
Economic Burden of Treatment-Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United StatesJay Lin, Holly Szukis, John J Sheehan, et al.Pageof 22